First-Line Treatment with Irinotecan and Raltitrexed in Metastatic Colorectal Cancer

Abstract

The combination of irinotecan plus raltitrexed is an easy comfortable schedule for patients with metastatic CRC, but both efficacy and toxicity results seem suboptimal for first-line treatment.